The Calmer Co International (ASX:CCO) — Material Events
ASX:CCO · 18 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
The Calmer Co Surges to $8M Revenue, Eyes 2026 BreakevenMedium
The Calmer Co posts $8M FY25 revenue with 86% growth, targets breakeven in 2026 amid strong global kava market expansion
3 Oct 2025
·Investor Presentation
·85
The Calmer Co’s US Sales Surge Past $1 Million, Driving Record Quarterly RevenueMedium
The Calmer Co posts record Q2 sales of $2.01M, U.S. sales surpass $1M and drive growth
30 Jan 2026
·Quarterly Results Presentation
·85
The Calmer Co. Smashes Sales Record with $910k December SurgeMedium
The Calmer Co. hits record $910k monthly sales in December, driven by wholesale and US market growth
14 Jan 2026
·ASX Release
·85
The Calmer Co. Secures Coles Ranging for Fiji Kava FZZR and Pushes U.S. Retail ExpansionMedium
The Calmer Co. secures Coles ranging for new Fiji Kava® FZZR™ product and advances U.S. retail expansion
24 June 2026
·Product Launch and Market Expansion Announcement
·85
FDA’s Food Classification Sparks Surge for The Calmer Co’s Kava BrandsMedium
FDA Classifies Kava as Food, Boosting The Calmer Co’s U.S. Growth and Amazon Sales
23 Dec 2025
·ASX Release
·Unexpected
·85
The Calmer Co. Posts Record $2.4M Quarter, Cuts Cash Outflows by 36%Medium
The Calmer Co. posts record Q1 FY26 revenue of $2.4M, reduces cash outflows, and secures $700k funding
28 Oct 2025
·Appendix 4C and Quarterly Activities Report
·85
The Calmer Co. Hits $2M Revenue Again with Record December SalesMedium
The Calmer Co. posts $2.01M Q2 revenue with record December sales and strengthens U.S. growth
30 Jan 2026
·Appendix 4C and Quarterly Activities Report
·80
The Calmer Co Hits Record $2.4M Sales in Q1, Eyes BreakevenMedium
The Calmer Co reports record $2.4M Q1 sales with strong retail and US growth
3 Oct 2025
·ASX Release
·80
The Calmer Co. Raises $700k, Boosts US Growth with Strategic InvestorMedium
The Calmer Co. raises $700k in convertible notes, welcomes strategic US investor Applied Food Sciences
29 Sept 2025
·Capital Raising
·80
The Calmer Co Surges 26% in Sales, Nears Break Even with Cash Use Down 39%Medium
The Calmer Co Q1 FY26 Sales Up 26%, Cash Use Down 39%, Nearing Break Even
28 Oct 2025
·Quarterly Results Presentation
·80
The Calmer Co. Taps Beverage Guru Tonkin to Lead U.S. ExpansionMedium
The Calmer Co. appoints James S. Tonkin as Chairman amid U.S. expansion push
7 Nov 2025
·Board and Corporate Governance Announcement
·75
The Calmer Co. Accelerates Growth with 86% Revenue Surge and New Channel WinsMedium
The Calmer Co. posts 6% quarterly revenue growth, FY25 revenue up 86%, advances towards breakeven
31 July 2025
·Appendix 4C and Quarterly Activities Report
·75
Calmer Co. Sales Soar 81% in July as Coles Footprint ExpandsMedium
The Calmer Co. Retail Sales Surge 81% in July, Expanding Coles Footprint
6 Aug 2025
·ASX Release
·75
Calmer Co. Accelerates Sales Growth with Leaner Model and New US ProductsMedium
Calmer Co. Reports Strong Sales Growth and Operational Improvements in H2 FY25
4 Sept 2025
·Trading Update
·75
The Calmer Co. Boosts RTD Capacity with FJ$548k Fiji Government GrantMedium
The Calmer Co. secures FJ$548k Fiji government grant to expand RTD production and supply chain
4 Mar 2026
·ASX Release
·70
The Calmer Co. Secures $1.4M to Fuel Wholesale ExpansionMedium
The Calmer Co. closes $1.4M convertible note raise to fund wholesale growth
18 Dec 2025
·Capital Raising
·70
Calmer Co. Posts 88% Revenue Surge Amid $4M Loss in FY2025Medium
Calmer Co. reports 88% revenue growth but $4M net loss for FY2025, no dividends declared
29 Aug 2025
·Appendix 4E Preliminary Final Report
·70
No articles in this tier for the last 12 months.
Market Mentions
1
- appeared in market wrap coverage
These are market wrap articles where The Calmer Co International (ASX:CCO) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 3 (12 Jan -> 16 Jan) 2026
18 Jan 2026